Proterris
Donald deBethizy has served as a member of their board of directors since 2013. Mr. deBethizy has 30 years of experience in research and development and financial, business and operating management in the biotechnology and consumer products industry. He currently serves as president of White City Consulting ApS. Previously, Mr. deBethizy served as president and chief executive officer of Santaris Pharma A/S until September 2014, when the company was sold to Roche.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Proterris
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.